JP2023547954A5 - - Google Patents
Info
- Publication number
- JP2023547954A5 JP2023547954A5 JP2023547721A JP2023547721A JP2023547954A5 JP 2023547954 A5 JP2023547954 A5 JP 2023547954A5 JP 2023547721 A JP2023547721 A JP 2023547721A JP 2023547721 A JP2023547721 A JP 2023547721A JP 2023547954 A5 JP2023547954 A5 JP 2023547954A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- compound according
- radioactive isotope
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020903727 | 2020-10-14 | ||
| AU2020903727A AU2020903727A0 (en) | 2020-10-14 | Conjugates and their use in therapy | |
| PCT/AU2021/051203 WO2022077068A1 (en) | 2020-10-14 | 2021-10-14 | Therapeutic radiolabelled conjugates and their use in therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023547954A JP2023547954A (ja) | 2023-11-14 |
| JP2023547954A5 true JP2023547954A5 (cg-RX-API-DMAC7.html) | 2024-10-25 |
| JP7890301B2 JP7890301B2 (ja) | 2026-07-14 |
Family
ID=81207378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023547721A Active JP7890301B2 (ja) | 2020-10-14 | 2021-10-14 | 治療用放射線標識コンジュゲート及び治療におけるそれらの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230398240A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4228710A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7890301B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230130610A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116472068A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021359638A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3195410A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL302033A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023004327A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022077068A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220152229A1 (en) | 2019-04-12 | 2022-05-19 | Centenary Institute Of Cancer Medicine And Cell Biology | Conjugates and their use as imaging agents |
| US20250269072A1 (en) * | 2021-10-14 | 2025-08-28 | Centenary Institute Of Cancer Medicine And Cell Biology | Processes for preparing radiolabelled conjugates |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100418585C (zh) * | 2003-07-24 | 2008-09-17 | 伯拉考成像股份公司 | 稳定的放射性药物组合物及制备方法 |
| WO2016088116A1 (en) * | 2014-12-05 | 2016-06-09 | University Health Network | Use of antioxidants as radio-protective agents |
| LT3275883T (lt) | 2015-03-25 | 2021-08-25 | Fujifilm Corporation | Naujo azotą turinčio junginio arba jo druskos gamybos būdas ir jo tarpinio junginio gamyba |
| US20160367620A1 (en) * | 2015-06-19 | 2016-12-22 | Harry B. Demopoulos | Glutathione |
| US20220152229A1 (en) * | 2019-04-12 | 2022-05-19 | Centenary Institute Of Cancer Medicine And Cell Biology | Conjugates and their use as imaging agents |
-
2021
- 2021-10-14 CA CA3195410A patent/CA3195410A1/en active Pending
- 2021-10-14 KR KR1020237015744A patent/KR20230130610A/ko active Pending
- 2021-10-14 CN CN202180075143.7A patent/CN116472068A/zh active Pending
- 2021-10-14 JP JP2023547721A patent/JP7890301B2/ja active Active
- 2021-10-14 WO PCT/AU2021/051203 patent/WO2022077068A1/en not_active Ceased
- 2021-10-14 IL IL302033A patent/IL302033A/en unknown
- 2021-10-14 AU AU2021359638A patent/AU2021359638A1/en active Pending
- 2021-10-14 EP EP21878793.5A patent/EP4228710A4/en active Pending
- 2021-10-14 MX MX2023004327A patent/MX2023004327A/es unknown
-
2023
- 2023-04-12 US US18/299,304 patent/US20230398240A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2880103T3 (es) | Derivados de benceno-1, 3, 5-tricarboxamida y usos de los mismos | |
| CA2990696C (en) | (r)- and (s)-1-(3-(3-n,n-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-n,n'-bis (ethylene)phosphoramidate, compositions and methods for their use and preparation | |
| EP3041468B1 (en) | Cyclic peptidomimetic compounds as immunomodulators | |
| JP2023533938A5 (cg-RX-API-DMAC7.html) | ||
| CA3042731A1 (en) | Inhibitors of interleukin-1 receptor-associated kinases and uses thereof | |
| CA2637765A1 (en) | Benzamide and heteroarene derivatives | |
| JP2006502143A5 (cg-RX-API-DMAC7.html) | ||
| US11420949B2 (en) | Cystine diamide analogs for the prevention of cystine stone formation in cystinuria | |
| JPS6187691A (ja) | 白金配位化合物 | |
| CA3157331A1 (en) | A pyrazolopyrimidine derivative as a hck inhibitor for use in therapy, in particular myd88 mutated diseases | |
| JP2023531970A5 (cg-RX-API-DMAC7.html) | ||
| US12043645B2 (en) | Adenosine analogs as methyltransferase inhibitors for treating cancer | |
| US10556875B2 (en) | Bis-diazeniumdiolate compounds as anti-cancer agents | |
| CN1942438A (zh) | 在肿瘤治疗中用来作为药物活性成分的脯氨酸衍生物 | |
| JP2005501121A5 (cg-RX-API-DMAC7.html) | ||
| WO2024064210A1 (en) | Small molecules for boron neutron capture therapy | |
| RU2010120810A (ru) | Гидратированные кристаллические сложные эфиры камптотецина для лечения рака | |
| US12221459B2 (en) | Cancer treatment with (2,2-bishydroxymethyl) methylenecyclopropane nucleotides | |
| EP0317956A2 (en) | Anti-tumor prodrugs | |
| WO2020033377A1 (en) | Histone demethylase 5 inhibitors and uses thereof | |
| CN1882365A (zh) | 金属三羰基络合物作为放射治疗化学毒性剂的用途 | |
| US8329879B2 (en) | H3LMN compound used as radioactive agent for treatment of liver cancer and manufacturing method thereof | |
| TW202227437A (zh) | 作為蛋白激酶抑制劑的取代的吡咯並[2, 3-b]吡啶及吡唑並[3,4-b]吡啶衍生物 | |
| CN113766952B (zh) | 放射性药品的制造方法及放射性药品 | |
| AU2009342892A1 (en) | Radiolabeled fluorine derivatives of methionine |